{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:19:57Z","timestamp":1791357597386,"version":"4.3.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","award":["M01 RR018535"],"award-info":[{"award-number":["M01 RR018535"]}],"id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH-64556"],"award-info":[{"award-number":["MH-64556"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH-60221"],"award-info":[{"award-number":["MH-60221"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1097\/01.chi.0000171904.23947.54","type":"journal-article","created":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T04:09:52Z","timestamp":1123474192000},"page":"1024-1031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Hematological Adverse Events in Clozapine-Treated Children and Adolescents"],"prefix":"10.1016","volume":"44","author":[{"given":"Ginny","family":"Gerbino-Rosen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Roofeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Andrew","family":"Tompkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Feryo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Nusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Kranzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Frederickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inika","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Rhinewine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Kumra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/01.chi.0000171904.23947.54_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.169.4.483","article-title":"Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland","volume":"169","author":"Atkin","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004850-199805000-00008","article-title":"Lithium and clozapine-induced neutropenia\/agranulocytosis","volume":"13","author":"Blier","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5694\/j.1326-5377.1998.tb141414.x","article-title":"Clozapine treatment in Australia: a review of haematological monitoring","volume":"168","author":"Copolov","year":"1998","journal-title":"Med J Aust"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib5","author":"Drug Information resources page"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.jcp.0000117428.05703.16","article-title":"Olanzapine-induced neutropenia: mechanism and treatment","volume":"24","author":"Duggal","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"suppl 6","key":"10.1097\/01.chi.0000171904.23947.54_bib7","first-page":"30","article-title":"Atypical antipsychotics in the treatment of children and adolescents: clinical applications","volume":"65","author":"Findling","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib8","author":"Finnerty"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.psy.41.2.150","article-title":"Olanzapine-induced neutropenia","volume":"41","author":"Gajwani","year":"2000","journal-title":"Psychosomatics"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib10","first-page":"429","article-title":"Clozapine-induced transient white blood count disorders","volume":"55","author":"Hummer","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.chi.0000145371.23122.5a","article-title":"Clozapine: its impact on aggressive behavior among children and adolescents with schizophrenia","volume":"44","author":"Kranzler","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archpsyc.1996.01830120020005","article-title":"Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison","volume":"53","author":"Kumra","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib13","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(03)13306-5","article-title":"New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis","volume":"361","author":"Leucht","year":"2003","journal-title":"Lancet"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1192\/bjp.175.6.576","article-title":"Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance","volume":"175","author":"Munro","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1440-1614.2001.0911f.x","article-title":"Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine","volume":"35","author":"Pantelis","year":"2001","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00004583-200302000-00008","article-title":"Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II","volume":"42","author":"Pappadopulos","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib17","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/106002809102501022","article-title":"Erythromycin-induced agranulocytosis","volume":"25","author":"Pastor","year":"1991","journal-title":"DICP"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib18","author":"Patient Characteristics resources page"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib19","author":"Prescription Medications resources page"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-199802000-00016","article-title":"Prevention of clozapine-induced neutropenia by pretreatment with lithium","volume":"18","author":"Silverstone","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1097\/01.chi.0000171904.23947.54_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/104454603322572697","article-title":"Clozapine-induced neutropenia in children: management with lithium carbonate","volume":"13","author":"Sporn","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"}],"container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709617640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709617640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:18:24Z","timestamp":1760192304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856709617640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0890856709617640"],"URL":"https:\/\/doi.org\/10.1097\/01.chi.0000171904.23947.54","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematological Adverse Events in Clozapine-Treated Children and Adolescents","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/01.chi.0000171904.23947.54","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}